The guidelines support the medication classs positive effects of slowing the progression of chronic kidney disease though the effects are likely not as strong as SGLT2i, another class of diabetes medications [39, 40]
Health Miracle Promises : From curing goiter to weight loss without diet or exercise, these benefits are exaggerated and unsupported by legitimate science
Guidance for industry diabetes mellitus evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes
Lancet , 397 (10278), 971984
Side effects such as hyperglycemia because of systemic suppression of -cell secretion, peripheral edema, hypotension, and headache limit its use
Market Access Strategies and Pharmaceutical Innovations in Diabetes Care and Obesity Drug Market Securing market access remains a complex challenge for pharmaceutical companies